Proposal Presentation1

Embed Size (px)

Citation preview

  • 8/13/2019 Proposal Presentation1

    1/12

    Scientific WritingProposals

  • 8/13/2019 Proposal Presentation1

    2/12

    Interaction effect of allopurinol with salam (Eugenia

    polyantha Wight) leaves infusion to blood uric acid

    levels of Rattus novergicus

    By Nadhifa Firdausi

    20080310160

    MEDICAL FACULTY and HEALTH SCIENCE

    MUHAMMADIYAH UNIVERSITY OF YOGYAKARTA

    2011

  • 8/13/2019 Proposal Presentation1

    3/12

    Chapter I

    Introduction

    A. Background

    Uric acid is the end product of purine metabolism (Putra,

    2006).

    Hyperuricemia is high level of uric acid in the blood, more

    than 7,0 mg/dl in men and more than 6,0 mg/dl in women.Hyperuricemia is a primary risk factor for gout

    (Tehupeiroy, 2006).

    Allopurinol is the most common treatment used to lower

    blood uric acid levels.

    Eugenia polyantha is one of herbal treatment for gout.

    Ariyanti et al (2007): Optimal dose is 2,5 g/kgBW.

    Drug and herb interaction: increases/decreases

    pharmacologic effect or toxicity.

  • 8/13/2019 Proposal Presentation1

    4/12

    B. The formulation of problemCan the interaction of allopurinol withE. polyantha leaves

    infusion influence blood uric acid levels on Rattus

    novergicus induced by chicken broth.

    C. The purpose of research

    To know the interaction effectiveness of allopurinol with

    E. polyantha leaves infusion to blood uric acid levels.

    D. The function of research

    To scientifically prove the interaction effect of allopurinol

    withE. polyantha leaves infusion to blood uric acid levels,

    so that, if proven to be effective can be further developed as

    an alternative treatment for gout.

    E. The objectivity of research

    Research by Ariyanti et al (2007) isE.polyantha leaves

    infusion effect in decreasing blood uric acid levels induced

    by potassium oxonate. Differences : allopurinol will be

    interact withE. polyantha leaves infusion.

  • 8/13/2019 Proposal Presentation1

    5/12

    Chapter II

    Literature Review

    A. Hyperuricemia Hyperuricemia may result from under-excretion or over-

    production of uric acid (Humes, 2001).

    Regarding the etiology hyperuricemia can be classified as

    primary, secondary and idiopathic hyperuricemia (Putra,

    2006).

    B. Allopurinol

    Allopurinol is a xanthine oxidase inhibitor

    The primary metabolite of allopurinol is alloxanthine

    (oxypurinol)

  • 8/13/2019 Proposal Presentation1

    6/12

    C. E. polyantha leaves

    Consist of chemical substances such as saponin,

    triterpenoid, flavonoid, polifenol, alkaloid, tannin, atsiri

    oil (Sudarsono et al., 2002).

    Flavonoid inhibit xanthine oxidase decreasing blood

    uric acid levels (Cos, 1998).

    Ariyanti et al (2007) :E. polyantha leaves infusion doses

    1,25 g/kgBW, 2,5 g/kgBW, and 5,0 g/kgBB can decreaseblood uric acid levels. Optimal dose is 2,5 g/kgBW.

    Utami (2008) : Ethanol water fraction of E. polyantha

    leaves doses of 210 mg/kgBW and 420 mg/kgBW have

    effect of decreasing blood uric acid levels equivalent

    with allopurinol 10 mg/kgBW.

  • 8/13/2019 Proposal Presentation1

    7/12

    D. Drug Interaction Drug-drug, drug-herb, drug-food, drug-other chemical

    substances. Caused by pharmacodynamic or pharmacokinetic

    mechanism.

    Pharmacodynamic: synergistic, additive, antagonistic

    effects.

    Pharmacokinetic: absorption, distribution,metabolism, excretion.

    - Drug and Herb Interaction

    Toxicity: minor, moderate, fatal

    Giving ngokilo (Gynura procumbens) leaves

    decoction along with ciprofloxacin is more effective in

    the treatment of UTI due toE. coli than ciprofloxacin

    or G. procumbens leaves decoction only.

  • 8/13/2019 Proposal Presentation1

    8/12

    Chapter III

    Research Methode

    A. Research designExperimental laboratory by pre and post test controlled

    group design.

    B. Research variables

    Independent variable:E. polyantha leaves infusion dose

    and allopurinol dose.

    Dependent variable: Blood uric acid levels.

    Controlled variable: age, gender, body weight, strain,

    animal feed, cage condition, and temperature.

    C. Research subject20 male albino rats (Rattus novergicus) strain wistar, age

    2,5 months, weight 200 g.

    D. Research toolsPan infusion, spuit injection, rat scale, cappilary pipe,

    flannelette.

  • 8/13/2019 Proposal Presentation1

    9/12

    E. Research materials

    Allopurinol 4,5 mg/kgBW and 10 mg/kgBW, fresh

    E. polyantha leaves, chicken broth powder 504 mg/kgBW,

    CMC-Na 0,5% and aquades.

    F. Research location and time

    Pharmacology laboratorium of Muhammadiyah

    University of Yogyakarta & LPPT of Gadjah Mada

    University Research time: may until july 2011

    G. Way of research

    Hyperuricemia induction

    28 days

    Induced chicken broth powder504 mg/kgBW/day

    Hyperuricemic

    rats

    0 day 21st day

    initial measurement

    of blood uric acid levels

    Pre test

  • 8/13/2019 Proposal Presentation1

    10/12

    Test of interaction effectiveness of allopurinol with

    E. polyantha leaves infusion

    Hyperuricemic

    rats

    I

    IV

    III

    II

    CMC-Na 0,5%

    Allopurinol10 mg/kgBW

    Allopurinol 4,5 mg/kgBW

    +E. polyantha leaves

    infusion 2,5 g/kgBW

    Allopurinol 4,5 mg/kgBW

    +E. polyantha leaves

    infusion 5 g/kgBW

  • 8/13/2019 Proposal Presentation1

    11/12

    During treatment, rats still be given chicken broth

    Measurement of blood uric acid levels:

    H. Data analysis

    Data normality test

    Normal distribution: Parametric (one way Anova).

    Not normal distribution: Nonparametric test.

    22nd day-28th dayTreatment

    Initialmeasuremnet

    Inducedhyperuricemia

    for 28 days

    Secondmeasurementin 21st day

    (pre test)

    Treatment

    21st day-28thday

    Thirdmeasurementin 28th day(post test)

  • 8/13/2019 Proposal Presentation1

    12/12

    Thank you